Sanofi India Peer Comparison

Snapshot Summary

Sanofi India Ltd. demonstrates solid profitability metrics with a high ROE and low debt, however, it struggles with revenue growth compared to its peers. Meanwhile, companies like Cipla and Mankind Pharma stand out with their strong growth trajectories and attractive valuations, positioning them well in the sector.

• Sanofi India Ltd. has the highest ROE at 36.10% but shows negative revenue growth YoY.
• Cipla Ltd. and Mankind Pharma Ltd. show strong revenue growth and solid profitability, making them top picks in the sector.
• Sanofi has a low debt-to-equity ratio, indicating financial stability, while some peers carry heavier debt loads.

• Cipla Ltd.: Strong growth (YoY revenue growth of 13.28%) coupled with attractive valuation metrics (PE of 23.73).
• Mankind Pharma Ltd.: Exceptional revenue growth (18.12% YoY) and strong profitability indicators with a low debt-to-equity ratio.

Stocks	CMP	Market Cap	P/E	ROCE (%)	Debt/Equity
SANOFI	₹5,117.55	₹11,786.02Cr	32.63	46.16%	-
SUNPHARMA	₹1,563.35	₹3,75,099.26Cr	87.59	17.60%	0.04
DIVISLAB	₹6,091.05	₹1,61,698.50Cr	73.20	16.46%	-
CIPLA	₹1,587.60	₹1,28,217.27Cr	23.73	22.77%	0.01
TORNTPHARM	₹3,581.55	₹1,21,215.77Cr	61.53	24.28%	0.57
DRREDDY	₹1,280.30	₹1,06,835.27Cr	15.50	26.86%	0.07
MANKIND	₹2,518.95	₹1,03,926.59Cr	55.18	28.38%	0.02

Explore

Watchlists

Command Palette

Sanofi India Peer Comparison

Snapshot Summary